Flixotide Evohaler 250mcg is a prescription-only preventer inhaler. It contains the active ingredient fluticasone propionate, a potent inhaled corticosteroid used for the long-term management and prophylactic treatment of asthma and chronic obstructive pulmonary disease (COPD) in adults and older adolescents.
Key Medical Details
-
Mechanism of Action: It works by directly reducing swelling, irritation, and mucus formation in the small airways of the lungs. This makes breathing easier and significantly lowers the frequency of asthma attacks over time.
-
Classification: This is a "preventer" medication. It cannot be used as a rescue or reliever inhaler to treat sudden, acute asthma attacks or breathing difficulties. A fast-acting bronchodilator (like Salbutamol/Ventolin) must always be used for immediate relief.
-
Therapeutic Onset: It must be used consistently every single day, even when you feel completely well. The therapeutic effects generally take between 4 to 7 days to fully manifest.
-
Device Specifications: The Evohaler is a pressurized metered-dose inhaler (pMDI) that delivers a precise aerosol spray when the canister is manually depressed. The standard unit contains 120 actuations (puffs).
Dosage and Administration
-
Adult Dosage: The standard starting dose for moderate to severe asthma typically ranges from 100 to 1,000 micrograms taken twice daily, adjusted by a physician to the lowest effective maintenance dose. Because the 250mcg strength is highly potent, it is classified as a high-dose steroid treatment and is rarely appropriate for children.
-
Crucial Administration Step: You must always rinse your mouth thoroughly with water and spit it out after every use. This mechanical rinsing removes residual medication from the oral cavity, which dramatically reduces the clinical risk of developing oral thrush (a fungal yeast infection) or throat irritation.
